Marker Therapeutics, Inc. (MRKR): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$18.66M
Year ended 2019-12-31
2017-12-31: -$8.44M2018-12-31: -$14.63M2019-12-31: -$18.66M-$18.66M
2017-12-31 Free Cash Flow (USD) 2019-12-31
Period endedFree Cash FlowChange YoYSource filing
2019-12-31-$18.66Mn/m2021-03-09, From 2019-01-01
2018-12-31-$14.63Mn/m2020-03-12, From 2018-01-01
2017-12-31-$8.44Mn/a2019-03-15, From 2017-01-01